World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
62549
World Ranking
9458
National Ranking
917

Overview

Peter M.A. Calverley is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine. Their scientific output includes 117 publications in medicine, with 87 specifically in pulmonary and respiratory medicine, highlighting a concentrated expertise in this domain.

Their research covers several interconnected subfields such as physiology, emergency medical services, cardiology and cardiovascular medicine, and surgery. Within these areas, they have explored various main topics, including chronic obstructive pulmonary disease (COPD) research, respiratory support and mechanisms, and asthma and other respiratory diseases. Additional topics of their study include respiratory and cough-related research, pediatric health and respiratory diseases, obstructive sleep apnea research, and lung cancer diagnosis and treatment.

Peter M.A. Calverley has contributed extensively to scientific literature, with notable frequent co-authors including Jadwiga A. Wedzicha, Jørgen Vestbo, James P. Allinson, Alberto Papi, and Bartolomé R. Celli. These collaborations indicate active engagement with leading figures in respiratory and pulmonary research.

The scientist has published regularly in respected journals and venues. Their most frequent publication venues are:

  • American Journal of Respiratory and Critical Care Medicine (16 publications)
  • ERJ Open Research (5 publications)
  • International Journal of COPD (3 publications)
  • European Respiratory Journal (3 publications)
  • Respiratory Research (2 publications)

Among their recent papers, some key works include:

  • Clinical significance and applications of oscillometry, 2022, European Respiratory Review
  • Machine Learning and Prediction of All-Cause Mortality in COPD, 2020, CHEST Journal
  • Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review, 2020, American Journal of Respiratory and Critical Care Medicine
  • FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease, 2020, International Journal of COPD
  • Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials, 2020, Respiratory Research

Best Publications

  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

    R A Pauwels;A S Buist;P M Calverley;C R Jenkins

  • Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

    B. R. Celli;W. MacNee;A. Agusti;Antonio R Anzueto

  • Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    John R. Hurst;Jørgen Vestbo;Jørgen Vestbo;Antonio Anzueto;Nicholas Locantore

  • An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea

    Mark B Parshall;Richard M Schwartzstein;Lewis Adams;Robert B Banzett

  • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

    Peter Calverley;Romain Pauwels;Jørgen Vestbo;Paul Jones

  • Characterisation of COPD heterogeneity in the ECLIPSE cohort

    Àlvar Agustí;Peter Ma Calverley;Bartolome R Celli;Harvey O Coxson

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

    Steven R Coughlin;Lynn Mawdsley;Julie A Mugarza;Peter M A Calverley

  • The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

    Jadwiga A. Wedzicha;Peter M. A. Calverley;Terence A. Seemungal;Gerry Hagan

  • Changes in forced expiratory volume in 1 second over time in copd

    Jørgen Vestbo;Jørgen Vestbo;Lisa D. Edwards;Paul D. Scanlon;Julie C. Yates

  • Outcomes for COPD pharmacological trials: From lung function to biomarkers

    M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe

  • Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

    Peter M A Calverley;Klaus F Rabe;Udo-Michael Goehring;Søren Kristiansen

  • Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease Results from the TORCH Study

    Bartolomé R. Celli;Nicola E. Thomas;Julie A. Anderson;Gary T. Ferguson

  • Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.

    Alvar Agustí;Lisa D. Edwards;Stephen I. Rennard;William MacNee

  • Oral Corticosteroids in Patients Admitted to Hospital With Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Randomised Controlled Trial

    L Davies;R M Angus;P M A Calverley

  • Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

    S Rennard;Marc Decramer;P M A Calverley;N B Pride

  • Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

    Leonardo M Fabbri;Peter M A Calverley;José Luis Izquierdo-Alonso;Daniela S Bundschuh

  • Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

    Jadwiga A. Wedzicha;Marc Miravitlles;John R. Hurst;Peter M.A. Calverley

  • Adherence to inhaled therapy, mortality, and hospital admission in COPD

    Jørgen Vestbo;Julie A Anderson;Peter Calverley;Bartolome Celli

  • Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial

    Patrick B. Murphy;Patrick B. Murphy;Sunita Rehal;Gill Arbane;Stephen Bourke;Stephen Bourke

Frequent Co-Authors

Jørgen Vestbo
Jørgen Vestbo University of Manchester
Bartolome R. Celli
Bartolome R. Celli Brigham and Women's Hospital
Emiel F.M. Wouters
Emiel F.M. Wouters Maastricht University
Ruth Tal-Singer
Ruth Tal-Singer GlaxoSmithKline (United Kingdom)
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Antonio Anzueto
Antonio Anzueto The University of Texas Health Science Center at San Antonio
Alvar Agusti
Alvar Agusti University of Barcelona
William MacNee
William MacNee University of Edinburgh
Stephen I. Rennard
Stephen I. Rennard University of Nebraska Medical Center
David A. Lomas
David A. Lomas University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative or complementary healthcare careers is easier than ever with flexible online degree programs. If you're interested in pharmacy but want distance learning options, check out the online pharmd programs, which can prepare you for patient-focused roles as a pharmacist from the comfort of your home.

For those more inclined towards managing health data, an online mhi (Master of Health Information Management) degree can open doors to leadership positions in healthcare information systems and administration.

Looking for a fast entry into the medical field? Affordable medical billing and coding online courses cost significantly less than traditional programs, allowing you to quickly become workforce-ready in administrative healthcare roles.

Finally, consider the growing need for advanced practice nurses. Affordable online fnp programs (Family Nurse Practitioner) offer a practical, cost-effective way for registered nurses to advance their clinical skills and provide primary care across diverse settings.

Best Scientists Citing Peter M.A. Calverley

Trending Scientists